VYOME HOLDINGS, INC. Deferred State and Local Income Tax Expense (Benefit)
VYOME HOLDINGS, INC. (HIND) reported Deferred State and Local Income Tax Expense (Benefit) of -$76.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2024-04-01
- VYOME HOLDINGS, INC. deferred state and local income tax expense (benefit) for fiscal 2022 was -$76.00K.
- VYOME HOLDINGS, INC. deferred state and local income tax expense (benefit) for fiscal 2021 was -$30.00K.
- VYOME HOLDINGS, INC. deferred state and local income tax expense (benefit) for fiscal 2020 was -$2.00K.
- VYOME HOLDINGS, INC. deferred state and local income tax expense (benefit) for fiscal 2019 was $0.00.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$76.00K 10-K · filed 2024-04-01 | |
| 2021-12-31 | -$30.00K 10-K · filed 2023-04-17 | $9.00K 10-K · filed 2022-04-08 |
| 2020-12-31 | -$2.00K 10-K · filed 2022-04-08 | $0.00 10-K · filed 2021-03-12 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-12 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 | |
| 2017-12-31 | $0.00 10-K · filed 2019-02-22 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-05 | |
| 2015-12-31 | $0.00 10-K · filed 2018-03-05 | |
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |